Understanding why hookworms resist treatment with pyrantel
Dissecting the mechanism of pyrantel resistance in hookworm
This study is looking into why some hookworms are becoming resistant to the medicine pyrantel, which is often used to treat infections, so we can create better tests and treatments for people, especially kids and pregnant women, who need help fighting these infections.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | George Washington University NIH-funded |
| Lab location | 1 site (Washington, United States) |
| Project ID | NIH-10764937 on NIH RePORTER |
What this research studies
This research investigates the mechanisms behind hookworm resistance to the drug pyrantel, which is commonly used to treat infections. By analyzing genetic mutations in hookworms, the study aims to develop molecular tests that can detect emerging drug resistance. This approach will help improve treatment strategies during mass drug administration programs, particularly in vulnerable populations such as children and pregnant women. The research focuses on understanding how resistance develops to ensure effective control of hookworm infections.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals living in developing countries who are at risk of hookworm infections, particularly children, pregnant women, and the elderly.
Not a fit: Patients who are not infected with hookworms or who live in regions where hookworm is not prevalent may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for hookworm infections, reducing anemia and improving health outcomes in affected populations.
How similar studies have performed: Other research has shown success in understanding drug resistance in parasitic infections, indicating that this approach could yield valuable insights.
Where this research is happening
Washington, United States
- George Washington University — Washington, United States (Active)
Researchers
- Principal investigator: Hawdon, John M — George Washington University
- Study coordinator: Hawdon, John M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.